Long term behavioral effects of functional dopaminergic neurons generated from human neural stem cells in the rat 6-OH-DA Parkinson's disease model. Effects of the forced expression of BCL-X L

Behavioural Brain Research

Volumn 232, Issue 1, 2012, Pages 225-232

  Ramos Moreno, Tania ^a   Castillo, Claudia G ^b   Martínez Serrano, Alberto ^a  

^a CSIC   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

Author keywords

6 OHDA lesion; Cognitive amelioration; Functional motor recovery; Human dopaminergic cell transplantation; Parkinson's disease

Indexed keywords

PROTEIN BCL XL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MATURATION; COGNITIVE DEFECT; DOPAMINERGIC NERVE CELL; FEMALE; IN VIVO STUDY; MESENCEPHALON; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SURVIVAL TIME; VENTRAL MESENCEPHALON;

ANIMALS; BCL-X PROTEIN; BEHAVIOR, ANIMAL; CELL LINE; CELL SURVIVAL; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITION DISORDERS; CORPUS STRIATUM; DEXTROAMPHETAMINE; DOPAMINERGIC NEURONS; FEMALE; FUNCTIONAL LATERALITY; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MAZE LEARNING; MICROSCOPY, FLUORESCENCE; MOTOR ACTIVITY; NEURAL STEM CELLS; OXIDOPAMINE; PARKINSON DISEASE, SECONDARY; RATS; RATS, SPRAGUE-DAWLEY; STEREOTYPED BEHAVIOR; SYMPATHOLYTICS;

EID: 84860345147     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.04.020     Document Type: Article

References (42)

1. Villa A., Liste I., Courtois E.T., Seiz E.G., Ramos M., Meyer M., et al. Generation and properties of a new human ventral mesencephalic neural stem cell line. Experimental Cell Research 2009, 315:1860-1874.
2. Courtois E.T., Castillo C.G., Seiz E.G., Ramos M., Bueno C., Liste I., et al. In vitro and in vivo enhanced generation of human A9 dopamine neurons from neural stem cells by Bcl-XL. Journal of Biological Chemistry 2010, 285:9881-9897.
3. Winkler C., Kirik D., Bjorklund A. Cell transplantation in Parkinson's disease: how can we make it work. Trends in Neurosciences 2005, 28:86-92.
4. Li J.Y., Christophersen N.S., Hall V., Soulet D., Brundin P. Critical issues of clinical human embryonic stem cell therapy for brain repair. Trends in Neurosciences 2008, 31:146-153.
5. Lindvall O., Kokaia Z. Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease. Trends in Pharmacological Sciences 2009, 30:260-267.
6. Lindvall O., Bjorklund A. Cell therapeutics in Parkinson's disease. Neurotherapeutics 2011, 8:539-548.
7. Lane E.L., Bjorklund A., Dunnett S.B., Winkler C. Neural grafting in Parkinson's disease unraveling the mechanisms underlying graft-induced dyskinesia. Progress in Brain Research 2010, 184:295-309.
8. Tonnesen J., Seiz E.G., Ramos M., Lindvall O., Martinez-Serrano A., Kokaia M. Functional properties of the human ventral mesencephalic neural stem cell line hVM1. Experimental Neurology 2010, 223:653-656.
9. Krabbe C., Courtois E., Jensen P., Jorgensen J.R., Zimmer J., Martinez-Serrano A., et al. Enhanced dopaminergic differentiation of human neural stem cells by synergistic effect of Bcl-xL and reduced oxygen tension. Journal of Neurochemistry 2009, 110:1908-1920.
10. Brundin P., Strecker R.E., Widner H., Clarke D.J., Nilsson O.G., Astedt B., et al. Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: immunological aspects, spontaneous and drug-induced behaviour, and dopamine release. Experimental Brain Research 1988, 70:192-208.
11. Brundin P., Bjorklund A. Survival of expanded dopaminergic precursors is critical for clinical trials. Nature Nanotechnology 1998, 1:537.
12. Geeta R., Ramnath R.L., Rao H.S., Chandra V. One year survival and significant reversal of motor deficits in parkinsonian rats transplanted with hESC derived dopaminergic neurons. Biochemical and Biophysical Research Communications 2008, 373:258-264.
13. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1986, Academic Press, Inc., New York. 2nd ed.
14. Montoya C.P., Campbell-Hope L.J., Pemberton K.D., Dunnett S.B. The staircase test: a measure of independent forelimb reaching and grasping abilities in rats. Journal of Neuroscience Methods 1991, 36:219-228.
15. Schallert T., Fleming S.M., Leasure J.L., Tillerson J.L., Bland S.T. CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 2000, 39:777-787.
16. Torres E.M., Dowd E., Dunnett S.B. Recovery of functional deficits following early donor age ventral mesencephalic grafts in a rat model of Parkinson's disease. Neuroscience 2008, 154:631-640.
17. Deacon R.M., Rawlins J.N. T-maze alternation in the rodent. Nature Protocols 2006, 1:7-12.
18. Moussa R., Poucet B., Amalric M., Sargolini F. Contributions of dorsal striatal subregions to spatial alternation behavior. Learning & Memory 2011, 18:444-451.
19. Liste I., Garcia-Garcia E., Bueno C., Martinez-Serrano A. Bcl-XL modulates the differentiation of immortalized human neural stem cells. Cell Death and Differentiation 2007, 14:1880-1892.
20. Perlow M.J., Freed W.J., Hoffer B.J., Seiger A., Olson L., Wyatt R.J. Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Science 1979, 204:643-647.
21. Lindvall O., Brundin P., Widner H., Rehncrona S., Gustavii B., Frackowiak R., et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 1990, 247:574-577.
22. Kim J.H., Auerbach J.M., Rodriguez-Gomez J.A., Velasco I., Gavin D., Lumelsky N., et al. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 2002, 418:50-56.
23. Ko J.Y., Lee H.S., Park C.H., Koh H.C., Lee Y.S., Lee S.H. Conditions for tumor-free and dopamine neuron-enriched grafts after transplanting human ES cell-derived neural precursor cells. Molecular Therapy 2009, 17:1761-1770.
24. Abrous D.N., Torres E.M., Dunnett S.B. Dopaminergic grafts implanted into the neonatal or adult striatum: comparative effects on rotation and paw reaching deficits induced by subsequent unilateral nigrostriatal lesions in adulthood. Neuroscience 1993, 54:657-668.
25. Rodter A., Winkler C., Samii M., Nikkhah G. Complex sensorimotor behavioral changes after terminal striatal 6-OHDA lesion and transplantation of dopaminergic embryonic micrografts. Cell Transplantation 2000, 9:197-214.
26. Roedter A., Winkler C., Samii M., Walter G.F., Brandis A., Nikkhah G. Comparison of unilateral and bilateral intrastriatal 6-hydroxydopamine-induced axon terminal lesions: evidence for interhemispheric functional coupling of the two nigrostriatal pathways. Journal of Comparative Neurology 2001, 432:217-229.
27. Dobrossy M.D., Dunnett S.B. Training specificity, graft development and graft-mediated functional recovery in a rodent model of Huntington's disease. Neuroscience 2005, 132:543-552.
28. Fricker-Gates R.A., Smith R., Muhith J., Dunnett S.B. The role of pretraining on skilled forelimb use in an animal model of Huntington's disease. Cell Transplantation 2003, 12:257-264.
29. Kumar R., Riddle L.R., Griffin S.A., Chu W., Vangveravong S., Neisewander J., et al. Evaluation of D2 and D3 dopamine receptor selective compounds on l-dopa-dependent abnormal involuntary movements in rats. Neuropharmacology 2009, 56:956-969.
30. von Horsten S., Exton M.S., Voge J., Schult M., Nagel E., Schmidt R.E., et al. Cyclosporine A affects open field behavior in DA rats. Pharmacology Biochemistry and Behavior 1998, 60:71-76.
31. Demirag A., Moray G., Ozdemir N., Hizel N., Bilgin N., Haberal M. Comparison of serum lipids, lipoproteins, and fibrinogen in patients with kidney transplantation and hemodialysis. Transplantation Proceedings 1998, 30:2052-2053.
32. Bensinger S.J., Tontonoz P. Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature 2008, 454:470-477.
33. Bohmer A.E., Brum L.M., Souza D.G., Correa A.M., Oses J.P., Viola G.G., et al. Chronic treatment with cyclosporine affects systemic purinergic parameters, homocysteine levels and vascular disturbances in rats. Chemico-Biological Interactions 2010, 188:15-20.
34. Selhub J., Miller J.W. The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. American Journal of Clinical Nutrition 1992, 55:131-138.
35. Charlton C.G., Crowell B. Parkinson's disease-like effects of S-adenosyl-l-methionine: effects of l-dopa. Pharmacology Biochemistry and Behavior 1992, 43:423-431.
36. Crowell B.G., Benson R., Shockley D., Charlton C.G. S-adenosyl-l-methionine decreases motor activity in the rat: similarity to Parkinson's disease-like symptoms. Behavioral and Neural Biology 1993, 59:186-193.
37. Kriks S., Shim J.W., Piao J., Ganat Y.M., Wakeman D.R., Xie Z., et al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature 2011, 480:547-551.
38. Vale S. Current management of the cognitive dysfunction in Parkinson's disease: how far have we come?. Experimental Biology & Medicine (Maywood) 2008, 233:941-951.
39. Da Cunha C., Angelucci M.E., Canteras N.S., Wonnacott S., Takahashi R.N. The lesion of the rat substantia nigra pars compacta dopaminergic neurons as a model for Parkinson's disease memory disabilities. Cellular and Molecular Neurobiology 2002, 22:227-237.
40. Miyoshi E., Wietzikoski S., Camplessei M., Silveira R., Takahashi R.N., Da Cunha C. Impaired learning in a spatial working memory version and in a cued version of the water maze in rats with MPTP-induced mesencephalic dopaminergic lesions. Brain Research Bulletin 2002, 58:41-47.
41. Chudasama Y., Robbins T.W. Functions of frontostriatal systems in cognition: comparative neuropsychopharmacological studies in rats, monkeys and humans. Biological Psychology 2006, 73:19-38.
42. Liste I., Garcia-Garcia E., Martinez-Serrano A. The generation of dopaminergic neurons by human neural stem cells is enhanced by Bcl-XL, both in vitro and in vivo. Journal of Neuroscience 2004, 24:10786-10795.